-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on Ardent Health, Lowers Price Target to $12

Benzinga·07/14/2026 13:25:15
Listen to the news
Truist Securities analyst David Macdonald maintains Ardent Health (NYSE:ARDT) with a Buy and lowers the price target from $13 to $12.